Prevalence of extended spectrum β-Lactamase-producing Enterobacteriaceae by phenotypic and genotypic methods in intensive care units in Tehran, Iran

Daru

Volumn 16, Issue 3, 2008, Pages 169-173

  Mirsalehian, A ^a   Akbari Nakhjavani, F ^a   Peymani, A ^a   Kazemi, B ^b   Jabal, Ameli F ^a   Mirafshar, S M ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Enterobacteriaceae; Extended Spectrum Lactamases (ESBLs); Intensive Care Unit (ICU)

Indexed keywords

CEPHALOSPORIN; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BETA LACTAMASE SHV GENE; BETA LACTAMASE TEM GENE; BLOOD SAMPLING; CHEMICAL ANALYSIS; CLINICAL AND LABORATORY STANDARDS INSTITUTE; DISK DIFFUSION; ENTEROBACTER; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GENOTYPE; HOSPITAL MANAGEMENT; HUMAN; INTENSIVE CARE UNIT; IRAN; KLEBSIELLA PNEUMONIAE; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVALENCE; SCORING SYSTEM; SCREENING TEST; SPUTUM; URINARY CATHETER; URINE; WOUND;

EID: 50949088989     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Jain A, Mondal R. Prevalence & antimicrobial resistance pattern of extended spectrum beta-lactamase producing Klebsiella spp isolated from cases of neonatal septicaemia. Indian J Med Res 2007; 125 : 89-94.
2. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update.Clin Microbiol Rev 2005; 18 : 657-86.
3. Jacoby GA. Beta-lactamase nomenclature. Antimicrob Agents Chemother 2006; 50 : 1123-9.
4. Linkin DR, Fishman NO, Patel JB, Merrill JD, Lautenbach E. Risk factors for extended-spectrum beta-lactamase-producing Enterobacteriaceae in a neonatal Intensive care unit. Infect Control Hosp Epidemiol 2004; 25: 781-3.
5. Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 15th informational supplement.Wayne, Pennsylvania: Clinical Laboratory Standards Institute Document M100-S15; 2005.
6. Stürenburg E, Mack D. Extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control. J Infect 2003; 47 : 273-95.
7. Antimicrobial susceptibility testing of Escherichia coli strains isolated from urinary tract infections to fluoroquinolones and detection of gyrA mutations in resistant strains. Akbari-Nakhjavani F., Mir-salehian A., Hamidian M., Kazemi B., Mirafshar M., Jabal Ameli F., Pajand O., Peymani AAkbari-Nakhjavani F., Mirsalehian A.,& et al. DARU, 2007;15:94-99
8. Sundsfjord A, Simonsen GS, Haldorsen BC, Haaheim H, Hjelmevoll SO, Littauer P, Dahl KH Genetic methods for detection of antimicrobial resistance. APMIS 2004; 112 : 815-37
9. Kollef MH, Fraser VJ. Antibiotic resistance in the intensive care unit. Ann Intern Med 2001 20; 134 : 298-314
10. Gaynes R, Edwards JR; National Nosocomial Infections Surveillance System. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 2005 15; 41 : 848-54
11. Kucukates E. Antimicrobial resistance among Gram-negative bacteria isolated from intensive care units in a Cardiology Institute in Istanbul, Turkey. Jpn J Infect Dis 2005;58 : 228-31
12. Bonfiglio G, Perilli M, Stefani S, Amicosante G, Nicoletti G. Prevalence of extended spectrum beta-lactamases among Enterobacteriaceae: an Italian survey. Int J Antimicrob Agents 2002; 19 : 213-7.
13. Nogueira Kda S, Higuti IH, Nascimento AJ, Terasawa LB, Oliveira S, Matos AP, Souza HA, Cogo LL, Dalla Costa LM. Occurrence of extended-spectrum beta-lactamases in Enterobacteriaceae isolated from hospitalized patients in Curitiba, southern Brazil. Braz J Infect Dis 2006; 10 : 390-5.
14. Ndugulile F, Jureen R, Harthug S, Urassa W, Langeland N. Extended spectrum beta-lactamases among Gram-negative bacteria of nosocomial origin from an intensive care unit of a tertiary health facility in Tanzania. BMC Infect Dis 2005; 5 : 86.
15. Feizabadi MM, Etemadi G, Yadegarinia D, Rahmati M, Shabanpoor S, Bokaei S. Antibiotic-resistance patterns and frequency of extended-spectrum beta-lactamase-producing isolates of Klebsiella pneumoniae in Tehran. Med Sci Monit. 2006; 12: 362-5.
16. Cao V, Lambert T, Nhu DQ, Loan HK, Hoang NK, Arlet G, Courvalin P. Distribution of extended-spectrum beta-lactamases in clinical isolates of Enterobacteriaceae in Vietnam.Antimicrob Agents Chemother 2002; 46 : 3739-43
17. Lavigne JP, Bouziges N, Chanal C, Mahamat A, Michaux-Charachon S, Sotto A. Molecular epidemiology of Enterobacteriaceae isolates producing extended-spectrum beta-lactamases in a French hospital. J Clin Microbiol 2004; 42 : 3805-8.
18. Spanu T, Luzzaro F, Perilli M, Amicosante G, Toniolo A, Fadda G. Occurrence of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to beta-lactams and other antimicrobial drugs. Antimicrob Agents Chemother 2002;46 : 196-202
19. Wu TL, Chia JH, Su LH, Kuo AJ, Chu C, Chiu CH. Dissemination of extended-spectrum beta-lactamase-producing Enterobacteriaceae in pediatric intensive care units. J Clin Microbiol 2003; 41 : 4836-8.
20. Shahcheraghi F, Moezi H, Feizabadi MM. Distribution of TEM and SHV beta-lactamase genes among Klebsiella pneumoniae strains isolated from patients in Tehran. Med Sci Monit 2007; 13 : 247-250.
21. Lal P, Kapil A, Das BK, Sood S. Occurrence of TEM & SHV gene in extended spectrum beta-lactamases (ESBLs) producing Klebsiella sp. isolated from a tertiary care hospital. Indian J Med Res 2007; 125 : 173-8